Global Fund Observer
Global Fund Observer is the leading independent voice providing insight, analysis and opinion about the Global Fund. For authoritative and credible explanations about the policies, practices and procedures at the Secretariat, to insider information about Global Fund Board meetings, to real stories capturing the impact and role of the Global Fund at the country level, subscribe to our free twice-monthly newsletter.
To avoid the risk of your email system treating incoming issues of Global Fund Observer as spam, you should add email@example.com to your list of approved email senders. If you are not sure how to do this, speak to your system administrator or technical support person.
Latest GFO Live articles
GFO Current Issue
The Global Fund’s recently published register of Unfunded Quality Demand reveals gaps in funding for men who have sex with men, sex workers, people who inject drugs, transgender people and other key affected populations.
With the first harm reduction program of its kind in the Middle Eastern region, Morocco is inspiring others to develop innovative ways to respond to the burgeoning twin threats of injecting drug use and HIV infection.
The ATHENA network says efforts to put women and girls at the center of Global Fund interventions in HIV, TB and malaria have yet to bear significant fruit at the country level.
The Eurasian Women’s Network on AIDS received funding from UN Women to train women's activists of 11 EECA countries in how to better integrate gender-specific approaches to HIV and AIDS as part of their national response to the disease.
In a report on the participation by representatives of key affected populations in southern African country coordinating mechanisms, Aidspan has found that some aspects of the type and quality of participation have improved but that more communication between the CCM and their membership and between their members and constituency is needed.
Investments in capacity-building to improve supply chain management and efficiency in resource-poor countries have failed to yield impressive results. Lloyd Matowe of Pharmaceutical Systems Africa suggests that a paradigm shift in the type and extent of technical assistance provided to countries is necessary.